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Lipogenesis in isolated human sebaceous glands from [U-YIJ]glucose, [UJ4C]leucine, [UJ4C]isoleucine, and 
[U-K]valine has been determined by thin-layer chromatography. Total lipogenesis from 2 mmol/l Iv- 
W]giucose was 114.8 sfc 22.3 pmol/gland per h (mean + SE), with 53.8% being incorporated into triglycer- 
ides, 20.25 into squalene, 12.8,% into phospholipids, 2.1% into cholesterol and 7.1% into wax monoester and 
cholesterol ester and 5% into di- and monoglycerides and free fatty acids. Total lipogenesis from 2 mmol/l 
[U-Wlleucine, 2 mmol/l &J-Wjisoleucine, and 2 mmol/l w-YZ]valine in the presence of 2 mmol/l glucose 
was 26, 29 and 9%, respectively, of that seen with 2 mmol/l glucose alone. The pattern of 14C distribution 
in the various lipid classes from the three U-IF-labelled branched-chain amino acids was not significantly 
different from that seen with p-W]glucose. 
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1. INTRODUCTION 
The study of the biochemistry and physiology of 
the human sebaceous gland has been hindered by 
the difficulty in isolating viable glands [1,2]. We 
have now described a technique of shearing which 
yields up to 30 glands within 3 h of biopsy and the 
glands have been shown to be viable as determined 
by light and electron microscopy, energy charge, 
and rates of i4C incorporation into total lipid 
following incubation with [U-‘4C]glucose [3]. 
However, no characterisation has yet been made of 
the different classes of lipid that isolated glands 
synthesise. This study reports, therefore, on the 
thin-layer chromatographic haracterisation of the 
lipids synthesised in vitro. 
Sebum contains an unusual class of mammalian 
lipid, the branched-chain fatty acid components of 
triglyceride and wax esters, which are predominant- 
ly the iso and anteiso-isomers (having a methyl 
substituent on the penultimate or ante-penultimate 
carbon atoms of the chains, respectively) but also 
smaller amounts in which a methyl branch occurs 
at other ~sitions in the chains, and fatty acids 
having two or three methyl branches 141. It has 
been suggested that these might derive from valine, 
leucine and isoleucine [4,5], but no study has yet 
been made on lipogenesis from branched chain 
amino acid and so it was decided to investigate 
this. 
2. MATERIALS AND METHODS 
L-Phosphatidylcholine, L-phosphatidic acid, L- 
phosphatidyleth~ol~ine, L-phosphatidylinosi- 
tol, L-phosphatidylse~ne, cardiolipin, L-lysoleci- 
thin, sphingomyelin, squalene, cholesterol n-de- 
cylate, n-hexadecane, cholesterol, monopalmitin, 
1,2-dipalmitin, 1,3-dipalmitin, stearic acid, tri- 
caprin and stearic acid stearyl ester were from 
Sigma. [U-‘4C]Glucose, [U-i4C]leucine, [U-‘4C]- 
isoleucine, [U-‘4C]valine, [4-14C]cholesterol, 1,2-d& 
[l-14C]palmitoyl-3-phosphatidylcholine, glycerol 
tri[l-14C]palmitate, were from Amersham Interna- 
tional. The solvents were from BDH and of the 
highest purity available. 
~bi~h~ by Ekevier Science Publishes B. V. (Bi5medicai rtivision) 
00145793/86/$3.50 0 1986 Federation of European Biochemical Societies 173 
Volume 200, number 1 FEBS LETTERS May 1986 
2.1. Isolation and maintenance of sebaceous 
glands 
Sebaceous glands were isolated by shearing [3]. 
Ethical Committee permission has been obtained. 
Glands were incubated overnight at 37°C in 10 ml 
tissue-culture medium RPMI-1640 (Gibco) sup- 
plemented with 5% (v/v) foetal calf serum (Gib- 
co), penicillin (Glaxo) (100 units/ml), streptomy- 
cin (Evans) (100 pglml) and buffered with 5% 
co2. 
2.2. Sebaceous gland lipogenesis 
Batches of 4-8 sebaceous glands were incubated 
for 3-5.25 h in 150 ~1 bicarbonate-buffered me- 
dium [6], equilibrated with 02 : CO2 (95 : 5) at 37°C 
with addition of radioactive glucose and amino 
acids as detailed in table 1. Following incubation, 
the glands were removed, blotted and total lipids 
extracted [7]. Control experiments howed that the 
rate of total lipogenesis was linear over 6 h for 
glucose and all 3 amino acids, and that the 
recovery of exogenous [4-14C]cholesterol and 
glycerol tri[l-14C]palmitate was over 90% when 
added to sebaceous glands and subjected to the 
lipid extraction procedure. 
2.3. ~denti~~at~o~ of lipid classes by thin-layer 
chromatography (TLC) 
The dried sebaceous gland lipid extract was 
redissolved in 100 ,ul chloroform-methanol-water 
(5 : 5 : 1, by vol.) and spotted onto a 20 x 20 cm 0.2 
mm silica gel chromatography plate. This was 
developed in solvent 1 (light petroleum 40-6O”C, 
diethyl ether, acetic acid [50:50: 1, by vol.]), sol- 
vent 2 (light petroleum 40-6O”C, benzene [70:30, 
v/v]), and solvent 3 (light petroleum 40-60’(Z), 
successively in the directions indicated in fig. 1. 
Polar lipid separation was effected by cutting the 
plate 3.5 cm from the base (interrupted line in 
fig.1) and developing in solvent 4 (chloroform, 
methanol, acetic acid, water [25 : 15 : 4 : 2, by vol.]) 
[8]. Each sebaceous gland extract test plate was 
developed concurrently with a lipid standard plate. 
Radioactivy spots on the test plate were located us- 
ing a Spark Chamber, and cut out, transferred into 
vials and counted by the external standard chan- 
nels ratio method until 2000 counts were collected. 
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Fig. 1. Thin-layer chromatogram of sebaceous gland lipid. Lipid extracts from sebaceous glands were separated by TLC 
as described in section 2. 
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Table 1 
Incorporation of substrates into sebaceous gland lipids 
May 1986 
Conditions of incubation 
2 mmol/l 2 mmol/l 2 mmol/l 2 mmol/l 2 mmol/l 
[U-14C]glucose [U-14C]glucose, [U-‘4C]valine, [U-r4C]iso- [U-‘4C]leucine, 
(n=5) 0.66 mmol/ 2 mmol/l leucine, 2 mmol/l 
leucine, glucose 2 mmol/I glucose 
0.66 mmoV1 (n=4) glucose (n=3) 
isoleucine, (n=3) 
0.66 mmol/l 
valine 
(n=4) 
Total lipid 
Lysolecithin + sphingomyelin 
Phosphatidylcholine 
Phosphatidylserine + , 
phosphatidylethanokmine + 
phosphatidylinositol 
Phosphatidic acid + 
cardiolipin 
Squalene 
Wax monoester + 
cholesterol ester 
Monoglyceride 
Cholesterol 
1,2-Diglyceride 
1,3-Diglyceride 
Free fatty acid 
Triglyceride 
Total phospholipids 
Total glyceride 
a Incorporation of 14C from a U-“C-1abelled branched-chain amino acid, in the presence of 2 mmol/l glucose, into total 
lipid was significantly different @<O.OS as determined by Mann-Whitney U test) when compared with the incorpora- 
tion of r4C from 2 mmolll [U-i4C]gIucose 
b Incorporation of 14C from a U-‘“C-labelled branched-chain amino acid, in the presence of 2 mmol/l glucose, into total 
lipid was significantly different (p<O.OS as determined by Mann-Whitney U test) when compared with the incorpora- 
tion of 14C from 2 mmol/l [U-r4C]glucose in the presence of 0.66 mmol/l leucine, 0.66 mmol/l isoleucine and 0.66 
mmol/l valine 
Values are expressed as pmol substrate inco~orated/gI~d per h and are means f SE (%) 
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114.8 + 22.3 84.4 f 36.8 10.2 i 2.4“*b 33.3 + 13.1* 30.0 + 18.5’ 
3.1 f 2.6 1.5 f 0.8 0.2 f 0.004 0.5 f 0.2 0.5 i 0.5 
(2.7%) (1.7%) (2.1%) (1.4%) (1.6%) 
5.0 + 1.6 7.8 + 4.5 1.2 * 0.2 1.9 f 0.2 2.3 i 0.3 
(4.3g70) (9.2%) 11.9%) (5.8%) (7.6%) 
3.4 f 1.1’ 
(2.8‘70) 2.2 + 0.8 0.7 f 0.2 
3.3 f 1.1 (2.6%) (7.1%) 
(2.8%) I 
23.2 f 6.7 11.4 f 6.2 0.2 f 0.05 
(20.2%) (13.3%) (2.1%) 
2.6 i 1.8 1.8 k 1.4 
(7.78/o) (6.1%) 
3.7 f 1.5 3.0 + 2.6 
(11.0%) (10.1%) 
8.2 zt 3.2 4.8 f 2.9 0.8 i 0.5 2.7 f 
(7.1%) (6.5~e) (7.4%) (8%) 
0.5 f 0.1 2.8 + 0.9 0.7 + 0.2 0.8 f 
(0.4%) (3.3%) (6.90/o) (3%) 
2.5 + 0.8 2.2 f 0.5 0.2 f 0.04 0.7 + 
(2.1%) (2.5%) (2.2%) (2.1%) 
1.4 + 0.5 3.7 f 1.9 0.3 * 0.1 0.6 + 
(1.1%) (4.4%) (2.6%) (1.7%) 
1.1 rt 0.1 2.3 + 1.1 0.5 f 0‘1 1.0 f 
(0.9%) (2.7Q/o) (4.8%) (2.9%) 
1.0 It 0.1 4.3 + 1.3 0.8 f 0.3 1.1 f 
(O.SCro) (5.0%) (7.3%) (3.1%) 
61.9 + 9.9 42.9 f 21.6 4.5 f 2.0 17.7 * 
(53.8%) (SO.SCro) (43.9%) (53.1%) 
14.8 + 3.3 9.6 i 4.3 2.2 + 0.3 5.0 + 
(12.8%) (13.6%) (21.3%) (15.1%) 
66.5 f 9.6 56.0 f 24.9 6.7 f 1.7 21.1 f 
(57.3%) (66.4%) (65.7%) (63.3%) 
1.2 
0.3 
0.4 
0.2 
0.5 
0.4 
8.0 
1.8 
8.9 
1.7 f 1.5 
(5.5%) 
1.8 f 0.6 
(6.0%) 
2.3 f 1.2 
(7.5%) 
0.8 + 0.1 
(3.3%) 
1.8 f 0.9 
(6.i%) 
2.3 f 0.8 
(7.7%) 
13.6 f 10 
(45.3%) 
36.8 i 2.3 
(15.3%) 
20.4 k 12.4 
(67.9%) 
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Each area of radioactivity corresponded to a lipid 
standard spot as identified by 2 ’ ,7 ’ -dichlorofluo- 
rescein spray under UV light. Control experiments 
showed that the recovery of radioactive tripalmi- 
tate, cholesterol and phosphatidylcholine after 
TLC was 90-98%. 
3. RESULTS AND DISCUSSION 
Fig.1 shows that TLC effects a satisfactory 
separation of the major sebum lipid classes except 
that cholesterol ester and wax monester have the 
same Rf value. 
Table 1 shows that the incorporation of 14C 
from [U-i4C]glucose into total lipid was 114.8 f
22.3 (mean f SE) which is approx. 2.5times that 
we have previously reported [3]. The only dif- 
ference in technique between the two studies is that 
the glands of this one were maintained overnight. 
This might have allowed any cell trauma associated 
with isolation to be corrected. 
Table 1 shows the incorporation of 14C from 
[U-14C]glucose into the various lipid classes. The 
composition of human sebum is not known pre- 
cisely because skin lipid derives from two sources, 
sebaceous glands and epidermal cells, and sebum 
cannot be collected without epidermal lipid con- 
tamination. However, the surface lipid from dif- 
ferent skin sites with known variations in sebaceous 
gland density has been sampled and it has been 
calculated [9] that the major classes of sebum lipid 
are: triglycerides, diglycerides, free fatty acids, 
57.5%; wax esters, 26%; squalene, 12%; choles- 
terol, 1.5%; cholesterol esters, 3%. It will be seen 
that calculation is in broad agreement with our 
reported pattern of [U-i4C]glycose incorporation. 
Sebaceous glands were incubated in U-r4C- 
labelled branched-chain amino acids in the expec- 
tation that their 14C incorporation would be con- 
centrated, relative to that of glucose, in the fatty 
acid-containing lipids because of the previous sug- 
gestion that they were the source of the branch 
points of fatty acids [4,5]. In the absence of such 
concentration (table 1) it remains to be shown 
whether the amino acids are indeed responsible for 
the fatty acid branch points. 
Table 1 shows that there appears to be substrate 
competition between glucose and the branched- 
176 
chain amino acids, and that there is significant 
catabolism of these essential amino acids. However, 
the relative concentration of these substrates in 
blood are so different in vivo (serum glucose con- 
centration is greater than 4.5 mmol/l [lo]; the 
branched-chain amino acids are approx. 0.1 mmol/l 
[ 111) that the actual loss in vivo of branched-chain 
amino acids in sebum may be small. The incor- 
poration of 14C from valine appeared to be much 
less than that for the other branched-chain amino 
acids and this may be a reflection of its exclusively 
gluconeogenic metabolism. 
ACKNOWLEDGEMENTS 
We thank Mrs J. Hodgson of the Department of 
Plant Biology for assistance with the spark cham- 
ber and the Northern Regional Health Authority 
for financial support. 
REFERENCES 
111 
121 
I31 
(41 
PI 
161 
[71 
PI 
191 
WI 
illI 
Shalita, A., Freinkel, R.K., Downing, D., Kligman, 
A., Leyden, N., Moutagne, W., Pochi, P., Puhvel, 
S.M., Reisnm, R.M., Strauss, J.S. and Sansone- 
Bazzano, G. (1979) J. Invest. Dermatol. 73, 
434-442. 
Hay, J.B. and Hodgins, M.B. (1978) J. Endo- 
crinol. 79, 29-39. 
Kealey, T., Lee, C.M., Thody, A.J. and Coaker, 
T. (1986) Br. J. Dermatol. 114, 181-188. 
Nicolaides, N., Apon, J.M.B. and Wong, D.H. 
(1976) Lipids 11, 781-790. 
Downing, D.T. and Strauss, J.S. (1974) J. Invest. 
Dermatol. 62, 228-244. 
Krebs, H.A. and Hensleit, K. (1932) Hopper- 
Seyler’s Z. Physiol. Chem. 210; 33-36. 
Bligh, E.G. and Dyer, W.J. (1959) Can. J. Bio- 
them. Physiol. 37, 911-917. 
Cooper, M.F., Thody, A. J., Shuster, S. (1974) Bio- 
chim. Biophys. Acta 360, 193-204. 
Greene, R.S., Downing, D.T., Pochi, P.E. and 
Strauss, J.S. (1970) J. Invest. Dermatol. 54, 240- 
247. 
Zilva, J.F. and Pannall, P.R. (1981) Clinical 
Chemistry in Diagnosis and Treatment, Lloyd- 
Luke, p. 175. 
Striver, C.R., Clow, C.L. and Lamm, P. (1971) 
Am. J. Clin. Nutr. 24, 876-890. 
